betulinic acid has been researched along with Cancer of Mouth in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DS; Pezzuto, JM; Pisha, E | 1 |
| Chen, C; Li, KY; Li, QF; Meng, Z; Xu, K; Yuan, DY; Zhang, B | 1 |
| Liu, L; Shen, H; Wei, K; Xun, W; Yang, Y; Zeng, G | 1 |
3 other study(ies) available for betulinic acid and Cancer of Mouth
| Article | Year |
|---|---|
Synthesis of betulinic acid derivatives with activity against human melanoma.
Topics: Antineoplastic Agents; Betulinic Acid; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Humans; Hydrogen Bonding; Melanoma; Mouth Neoplasms; Pentacyclic Triterpenes; Triterpenes | 1998 |
Betulinic acid increases radiosensitization of oral squamous cell carcinoma through inducing Sp1 sumoylation and PTEN expression.
Topics: Betulinic Acid; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Gene Expression Regulation, Neoplastic; Humans; Mouth Neoplasms; Pentacyclic Triterpenes; PTEN Phosphohydrolase; Radiation Tolerance; Sp1 Transcription Factor; Sumoylation; Triterpenes | 2017 |
Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Betulinic Acid; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Genes, Reporter; Humans; Male; Mice; Mouth Neoplasms; Pentacyclic Triterpenes; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Triterpenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |